凝块管理设备市场——增长、趋势、COVID-19 影响和预测 (2023 - 2028)

凝块管理器械市场按产品(取栓球囊导管、导管导向溶栓装置、经皮取栓装置、下腔静脉过滤器、神经血管栓塞切​​除装置)、最终用户和地理区域划分

凝块管理设备市场快照

Clot Management Devices Market Overview
share button
Study Period 2018 - 2026
Base Year For Estimation 2022
Forecast Data Period 2023 - 2028
CAGR 4.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Clot Management Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

血栓管理设备增长的关键驱动因素包括心血管疾病患病率的增加、老年人口的增加和意识的提高,这导致血栓管理设备的使用增加。根据世界卫生组织 (WHO) 的数据,心血管疾病每年导致全球 1790 万人死亡。此外,中风和心脏病发病率的增加,对治疗血栓的微创手术的需求不断增长,预计将推动市场增长。

此外,血栓管理技术的进步和公司在创新血栓管理治疗方法方面的努力正在进一步推动市场增长。然而,严格的监管政策和替代疗法的可用性预计将阻碍市场增长。

报告范围

在血管中形成血栓称为血栓形成(血液凝固)。这会阻止动脉或静脉中的血液循环。血块管理装置有助于去除或溶解血块并恢复血液循环。

By Product
Embolectomy Balloon Catheter
Catheter Directed Thrombolysis Devices
Percutaneous Thrombectomy Devices
Inferior Vena cava Filters
Neurovascular Embolectomy Devices
By End-User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

神经血管栓子切除术有望显着增长

  • 由于研发投资的增加和产品技术的不断创新,预计神经血管栓塞切​​除术将具有显着的增长率。
  • 此外,对微创手术的需求不断增长,加上患者对这些治疗的认识不断提高,预计将推动该细分市场的增长。
  • 根据世界卫生组织 (WHO) 的数据,患有深静脉血栓形成 (DVT) 和肺栓塞 (PE) 的人数远远多于患有艾滋病和癌症的人数。2015 年,美国约有 9,00,000 人被诊断为 DVT 和 PE。
  • 此外,作为中风高危因素的髋、膝和脊柱手术的增加预计将推动与中风相关的导管导向溶栓市场。此外,久坐不动的生活方式和不健康的饮食习惯导致肥胖和其他与静脉相关的疾病,预计将在预测期内推动市场增长。
Clot Management Devices Market Key Trends

竞争格局

全球凝块管理设备市场适度整合和竞争。市场参与者正专注于产品创新、新产品发布和区域扩张,以增加其市场份额。在凝块管理设备市场运营的主要市场参与者包括 Medtronic Plc、Boston Scientific Corporation、Edward Lifesciences、AngioDynamics, Inc. 和 LeMaitre Vascular, Inc. 等。

主要玩家

  1. Medtronic Plc

  2. Boston Scientific Corporation

  3. Edward Lifesciences

  4. AngioDynamics, Inc.

  5. LeMaitre Vascular, Inc.

*Disclaimer: Major Players sorted in no particular order

Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics, Inc. ,LeMaitre Vascular, Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Ageing Population

      2. 4.2.2 Growing Demand for Minimally Invasive Surgeries and Advancements in Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Procedures

      2. 4.3.2 Availability of Alternative Treatments

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Embolectomy Balloon Catheter

      2. 5.1.2 Catheter Directed Thrombolysis Devices

      3. 5.1.3 Percutaneous Thrombectomy Devices

      4. 5.1.4 Inferior Vena cava Filters

      5. 5.1.5 Neurovascular Embolectomy Devices

    2. 5.2 By End-User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Surgical Centers

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic Plc

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Edward Lifesciences

      4. 6.1.4 Teleflex Incorporated

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 LeMaitre Vascular, Inc.

      7. 6.1.7 Strub Medical GmbH & Co. KG

      8. 6.1.8 AngioDynamics

      9. 6.1.9 iVascular SLU

      10. 6.1.10 Cook Group Incorporated

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

凝块管理设备市场的研究时间为 2018 年至 2028 年。

未来 5 年,血块管理设备市场将以 4.5% 的复合年增长率增长。

亚太地区在 2018 年至 2028 年期间的复合年增长率最高。

北美在 2021 年的份额最高。

Medtronic Plc、Boston Scientific Corporation、Edward Lifesciences、AngioDynamics, Inc.、LeMaitre Vascular, Inc. 是在凝块管理设备市场运营的主要公司。

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!